GSK Paxil Hemihydrate Patent Claim Invalid, Court Says In Ruling For Apotex

SmithKline’s early clinical trials on the safety and efficacy of paroxetine hemihydrate as an antidepressant did not constitute an “experimental use” of the claimed invention, the court says.

More from Archive

More from Pink Sheet